{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:54:22Z","timestamp":1789818862416,"version":"4.0.1"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T00:00:00Z","timestamp":1432857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003820","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T18:32:17Z","timestamp":1432924337000},"page":"e0003820","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Ex Vivo Host and Parasite Response to Antileishmanial Drugs and Immunomodulators"],"prefix":"10.1371","volume":"9","author":[{"given":"Laura","family":"Gonzalez-Fajardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga Luc\u00eda","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"McMahon-Pratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy Gore","family":"Saravia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,5,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Elting LS, Rubenstein EB, Rolston KVI, Bodey GP. Outcomes of Bacteremia in Patients with Cancer and Neutropenia: Observations from Two Decades of Epidemiological and Clinical Trials. Clinical Infectious Diseases1997. p. 247\u201359.","DOI":"10.1086\/514550"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1473-3099(11)70031-7","article-title":"Consequences of HIV infection on malaria and therapeutic implications: a systematic review","volume":"11","author":"C Flateau","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/cid\/cir508","article-title":"Tuberculosis of the central nervous system in immunocompromised patients: HIV infection and solid organ transplant recipients","volume":"53","author":"CA Nelson","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-0-387-09550-9_11","article-title":"The damage-response framework of microbial pathogenesis and infectious diseases","volume":"635","author":"LA Pirofski","year":"2008","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1086\/653829","article-title":"T-bet, GATA-3, and Foxp3 expression and Th1\/Th2 cytokine production in the clinical outcome of human infection with Leishmania (Viannia) species","volume":"202","author":"YR Diaz","year":"2010","journal-title":"J Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fimmu.2012.00301","article-title":"Protective and pathologic immune responses in human tegumentary leishmaniasis","volume":"3","author":"LP Carvalho","year":"2012","journal-title":"Front Immunol"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/pim.12007","article-title":"Tissue damage and immunity in cutaneous leishmaniasis","volume":"34","author":"S Nylen","year":"2012","journal-title":"Parasite Immunol"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/IAI.01513-08","article-title":"Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials","volume":"77","author":"A Maurer-Cecchini","year":"2009","journal-title":"Infect Immun"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"e1866","DOI":"10.1371\/journal.pntd.0001866","article-title":"Human macrophage response to L. (Viannia) panamensis: microarray evidence for an early inflammatory response","volume":"6","author":"C Ramirez","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref10","first-page":"819512","article-title":"Host cell signalling and leishmania mechanisms of evasion","volume":"2012","author":"MT Shio","year":"2012","journal-title":"J Trop Med"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1128\/AAC.01196-07","article-title":"Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection","volume":"52","author":"J Mookerjee Basu","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"e25356","DOI":"10.1371\/journal.pone.0025356","article-title":"Differential modulation of ATP-induced P2X7-associated permeabilities to cations and anions of macrophages by infection with Leishmania amazonensis","volume":"6","author":"C Marques-da-Silva","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jac\/dkt334","article-title":"Leishmania panamensis infection and antimonial drugs modulate expression of macrophage drug transporters and metabolizing enzymes: impact on intracellular parasite survival","volume":"69","author":"MA Gomez","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0210088","article-title":"Editorial: Leishmania survival mechanisms: the role of host phosphatases","volume":"88","author":"MT Shio","year":"2010","journal-title":"J Leukoc Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"165126","DOI":"10.1155\/2012\/165126","article-title":"Innate immune activation and subversion of Mammalian functions by leishmania lipophosphoglycan","volume":"2012","author":"LH Franco","year":"2012","journal-title":"J Parasitol Res"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.2042-7158.2011.01385.x","article-title":"The effect of propolis on CCL5 and IFN-gamma expression by peripheral blood mononuclear cells from leishmaniasis patients","volume":"64","author":"MK Amarante","year":"2012","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jac\/dkr409","article-title":"The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis","volume":"67","author":"RF Rodrigues","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.1128\/AAC.01146-09","article-title":"The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells","volume":"53","author":"S Mendez","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1084\/jem.172.1.391","article-title":"Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin\/tumor necrosis factor synthesis at separate points in the signaling pathway","volume":"172","author":"J Han","year":"1990","journal-title":"J Exp Med"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1086\/511643","article-title":"Oral Pentoxifylline Combined with Pentavalent Antimony: A Randomized Trial for Mucosal Leishmaniasis","volume":"44","author":"PRL Machado","year":"2007","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4269\/ajtmh.12-0729","article-title":"Clinical and immunological outcome in cutaneous leishmaniasis patients treated with pentoxifylline","volume":"90","author":"G Brito","year":"2014","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/eji.200535602","article-title":"Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO","volume":"36","author":"G Wingender","year":"2006","journal-title":"Eur J Immunol"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/eji.200838184","article-title":"Excessive CpG 1668 stimulation triggers IL-10 production by cDC that inhibits IFN-alpha responses by pDC","volume":"38","author":"Z Waibler","year":"2008","journal-title":"Eur J Immunol"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.addr.2008.12.008","article-title":"Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists","volume":"61","author":"J Vollmer","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.cellimm.2011.08.001","article-title":"Reduced efficacy of multiple doses of CpG-matured dendritic cell tumor vaccine in an experimental model","volume":"271","author":"A Pourgholaminejad","year":"2011","journal-title":"Cell Immunol"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.uct.2007.11.003","article-title":"CpG oligodeoxynucleotides as immunotherapy in cancer","volume":"3","author":"B Jahrsdorfer","year":"2008","journal-title":"Update Cancer Ther"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.addr.2008.12.007","article-title":"Use of CpG oligonucleotides in treatment of asthma and allergic disease","volume":"61","author":"DE Fonseca","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"e94596","DOI":"10.1371\/journal.pone.0094596","article-title":"Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasis","volume":"9","author":"R Shivahare","year":"2014","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1471-2334-14-108","article-title":"CD4 T cell activation by B cells in human Leishmania (Viannia) infection","volume":"14","author":"D Rodriguez-Pinto","year":"2014","journal-title":"BMC Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jim.2014.04.005","article-title":"Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials","volume":"409","author":"A Sambor","year":"2014","journal-title":"J Immunol Methods"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/infdis\/172.4.1157","article-title":"Drug cytotoxicity assay for African trypanosomes and Leishmania species","volume":"172","author":"AL Bodley","year":"1995","journal-title":"J Infect Dis"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2249.2005.02848.x","article-title":"Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium","volume":"141","author":"G Pedersen","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/10428194.2011.606944","article-title":"Therapeutic Toll-like receptor agonists directly influence mouse and human T cell lymphoma cell viability and cytokine secretion","volume":"53","author":"A Landrigan","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1645\/GE-3489.1","article-title":"Selective action of fluoroquinolones against intracellular amastigotes of Leishmania (Viannia) panamensis in vitro","volume":"91","author":"IC Romero","year":"2005","journal-title":"J Parasitol"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0166-6851(00)00270-X","article-title":"Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models","volume":"110","author":"G Roy","year":"2000","journal-title":"Mol Biochem Parasitol"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1086\/503371","article-title":"Resistance to antimony and treatment failure in human Leishmania (Viannia) infection","volume":"193","author":"R Rojas","year":"2006","journal-title":"J Infect Dis"},{"issue":"Suppl","key":"ref37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-3083.1976.tb03851.x","article-title":"Isolation of lymphocytes, granulocytes and macrophages","volume":"5","author":"A Boyum","year":"1976","journal-title":"Scand J Immunol"},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1128\/AAC.49.9.3776-3783.2005","article-title":"Use of Leishmania donovani field isolates expressing the luciferase reporter gene in in vitro drug screening","volume":"49","author":"Ashutosh","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"ref39","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1128\/JCM.00216-12","article-title":"Novel approach to in vitro drug susceptibility assessment of clinical strains of Leishmania spp","volume":"50","author":"O Fernandez","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-3083.2000.00724.x","article-title":"Distinct innate and acquired immune responses to Leishmania in putative susceptible and resistant human populations endemically exposed to L. (Viannia) panamensis infection","volume":"51","author":"F Bosque","year":"2000","journal-title":"Scand J Immunol"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"e962","DOI":"10.1371\/journal.pntd.0000962","article-title":"Identification of small molecule lead compounds for visceral leishmaniasis using a novel ex vivo splenic explant model system","volume":"5","author":"Y Osorio","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1354\/vp.42-2-166","article-title":"Cutaneous leishmaniasis in naturally infected dogs is associated with a T helper-2-biased immune response","volume":"42","author":"C Brachelente","year":"2005","journal-title":"Vet Pathol"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1128\/AAC.50.4.1238-1244.2006","article-title":"Nanodisk-associated amphotericin B clears Leishmania major cutaneous infection in susceptible BALB\/c mice","volume":"50","author":"KG Nelson","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"3\u20134","key":"ref44","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0001-706X(92)90042-V","article-title":"An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1","volume":"51","author":"A Gebre-Hiwot","year":"1992","journal-title":"Acta Trop"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1086\/510860","article-title":"Pharmacokinetics of Antimony in Children Treated for Leishmaniasis with Meglumine Antimoniate","volume":"195","author":"A Cruz","year":"2007","journal-title":"Journal of Infectious Diseases"},{"issue":"8","key":"ref46","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/AAC.00014-08","article-title":"Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients","volume":"52","author":"TP Dorlo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0008-8749(92)90135-C","article-title":"Hexadecylphosphocholine induces interferon-gamma secretion and expression of GM-CSF mRNA in human mononuclear cells","volume":"141","author":"CH Hochhuth","year":"1992","journal-title":"Cell Immunol"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bbalip.2012.10.008","article-title":"Anticancer mechanisms and clinical application of alkylphospholipids","volume":"1831","author":"WJ van Blitterswijk","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1179\/136485905X19810","article-title":"Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate","volume":"99","author":"F Garcia-Cordoba","year":"2005","journal-title":"Ann Trop Med Parasitol"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/505217","article-title":"A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection","volume":"43","author":"K Ritmeijer","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"6","key":"ref51","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1365-4632.2006.03096.x","article-title":"Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids\u2014first report","volume":"46","author":"FF Tuon","year":"2007","journal-title":"Int J Dermatol"},{"issue":"5","key":"ref52","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/315890","article-title":"Interleukin-12 Regulates the Response to Chemotherapy in Experimental Visceral Leishmaniasis","volume":"182","author":"HW Murray","year":"2000","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"ref53","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/AAC.45.6.1872-1875.2001","article-title":"Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice","volume":"45","author":"P Escobar","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"ref54","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.intimp.2008.07.011","article-title":"Meglumine antimonate directly increases phagocytosis, superoxide anion and TNF-alpha production, but only via TNF-alpha it indirectly increases nitric oxide production by phagocytes of healthy individuals, in vitro","volume":"8","author":"MI Muniz-Junqueira","year":"2008","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"ref55","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/jir.2008.0061","article-title":"Interferon-gamma is induced in human peripheral blood immune cells in vitro by sodium stibogluconate\/interleukin-2 and mediates its antitumor activity in vivo","volume":"29","author":"K Fan","year":"2009","journal-title":"J Interferon Cytokine Res"},{"issue":"11","key":"ref56","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.4049\/jimmunol.0803859","article-title":"Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response","volume":"182","author":"P Wadhone","year":"2009","journal-title":"J Immunol"},{"issue":"9","key":"ref57","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/infdis\/jir551","article-title":"Miltefosine effectively modulates the cytokine milieu in Indian post kala-azar dermal leishmaniasis","volume":"204","author":"D Mukhopadhyay","year":"2011","journal-title":"J Infect Dis"},{"issue":"4","key":"ref58","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.intimp.2012.02.002","article-title":"Miltefosine triggers a strong proinflammatory cytokine response during visceral leishmaniasis: role of TLR4 and TLR9","volume":"12","author":"AK Mukherjee","year":"2012","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"ref59","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.4049\/jimmunol.180.9.6139","article-title":"Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis","volume":"180","author":"A Salhi","year":"2008","journal-title":"J Immunol"},{"issue":"10","key":"ref60","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/eji.201040384","article-title":"Murine model of chronic L. (Viannia) panamensis infection: Role of IL-13 in disease","volume":"40","author":"TM Castilho","year":"2010","journal-title":"European Journal of Immunology"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.micpath.2013.02.004","article-title":"Cytokines and NO in American tegumentary leishmaniasis patients: profiles in active disease, after therapy and in self-healed individuals","volume":"57","author":"M de Assis Souza","year":"2013","journal-title":"Microb Pathog"},{"issue":"5","key":"ref62","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/AAC.50.5.1788-1797.2006","article-title":"Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages","volume":"50","author":"J Mookerjee Basu","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"ref63","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0192-0561(97)85556-7","article-title":"Differential regulation of TNF alpha, IL-1 beta, IL-6, IL-8, TNF beta, and IL-10 by pentoxifylline","volume":"18","author":"CL D'Hellencourt","year":"1996","journal-title":"Int J Immunopharmacol"},{"issue":"6","key":"ref64","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-3083.2006.001761.x","article-title":"Effect of pentoxifylline on levels of pro-inflammatory cytokines during chronic hepatitis C","volume":"63","author":"G Gutierrez-Reyes","year":"2006","journal-title":"Scand J Immunol"},{"issue":"10","key":"ref65","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.intimp.2008.03.020","article-title":"Pentoxifylline down modulate in vitro T cell responses and attenuate pathology in Leishmania and HTLV-I infections","volume":"8","author":"A Ribeiro de Jesus","year":"2008","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"ref66","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3109\/02770900903089998","article-title":"Effects of tranilast and pentoxifylline in a mouse model of chronic asthma using house dust mite antigen","volume":"46","author":"SJ Kim","year":"2009","journal-title":"J Asthma"},{"issue":"6","key":"ref67","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1128\/AAC.48.6.2314-2317.2004","article-title":"Immunopharmacology of CpG oligodeoxynucleotides and ribavirin","volume":"48","author":"J Vollmer","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003820","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T14:41:33Z","timestamp":1540305693000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003820"}},"subtitle":[],"editor":[{"given":"Ricardo Toshio","family":"Fujiwara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,29]]},"references-count":67,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003820","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,29]]}}}